Skip to main content
MedPathMedPath Home
Clinical Trials/EUCTR2010-019997-33-NL
EUCTR2010-019997-33-NL
Active, not recruiting
Not Applicable

Responsiveness to botulinum toxinum type A in complex regional pain syndrome related fixed dystonia

eiden University Medical Center0 sitesApril 14, 2010
Share to TwitterShare to FacebookShare to LinkedInShare to Reddit
DrugsBotox

Overview

Phase
Not Applicable
Intervention
Not specified
Conditions
Not specified
Sponsor
eiden University Medical Center
Status
Active, not recruiting
Last Updated
14 years ago
OverviewInvestigatorsEligibility CriteriaOutcomesSimilar Trials

Overview

Brief Summary

No summary available.

Registry
who.int
Start Date
April 14, 2010
End Date
TBD
Last Updated
14 years ago
Study Type
Interventional clinical trial of medicinal product
Sex
All

Investigators

Sponsor
eiden University Medical Center

Eligibility Criteria

Inclusion Criteria

  • •CRPS with fixed dystonia of one lower extremity, age between 18 and 50, botulinum toxin naive
  • •Are the trial subjects under 18? no
  • •Number of subjects for this age range:
  • •F.1\.2 Adults (18\-64 years) yes
  • •F.1\.2\.1 Number of subjects for this age range
  • •F.1\.3 Elderly (\>\=65 years) no
  • •F.1\.3\.1 Number of subjects for this age range

Exclusion Criteria

  • •neuromuscular junction diseases, pregnancy/nursing women

Outcomes

Primary Outcomes

Not specified

Similar Trials

Completed
Not Applicable
Responsiveness to botulinum toxinum type A in complex regional pain syndrome related fixed dystonia10028037post traumatic dystrophyreflex sympathetic dystrophy
NL-OMON34320eids Universitair Medisch Centrum56
Completed
Not Applicable
comparison of the effect of botulinium toxin A injection with placebo in reducing the pain of patients with myofacial paitemporomandibular disorder.Temporomandibular joint disorders
IRCT2016051527894N2Vice chancellor for research of Ahvaz Jundishapur University of Medical Sciences34
Active, not recruiting
Phase 4
To check wrinkle free forehead after injection of Botulinum drug.
CTRI/2015/03/005613Dr L Krishna Prasad Head of department Department of oral and maxillofacial surgery
Completed
Phase 2
Botulinum toxin for nocturnal bruxism.
ACTRN12618001430224Melbourne Health41
Completed
Phase 2
Assessment of the botulinum toxin type A effect on Intensified Raynauds Phenomenon in Sclerodermic patientsSystemic sclerosis [scleroderma].Systemic sclerosis [scleroderma]
IRCT20200106046023N1Oroumia University of Medical Sciences11